1379TiPPhase I/II study of S 49076, a MET/AXL/FGFR inhibitor, in combination with gefitinib in EGFR-mutated NSCLC patients who progress on EGFR tyrosine kinase inhibitor. (18th September 2017)

Record Type:: Journal Article
Title:: 1379TiPPhase I/II study of S 49076, a MET/AXL/FGFR inhibitor, in combination with gefitinib in EGFR-mutated NSCLC patients who progress on EGFR tyrosine kinase inhibitor. (18th September 2017)
Main Title:: 1379TiPPhase I/II study of S 49076, a MET/AXL/FGFR inhibitor, in combination with gefitinib in EGFR-mutated NSCLC patients who progress on EGFR tyrosine kinase inhibitor
Authors:: Park, K.
Ciardiello, F.
Hida, T.
Lim, W.
Lin, C-C.
Murakami, H.
Nishio, M.
Cantero, F.
Cattan, V.
Gabarroca, C.
Gandossi, E.
Paz-Ares, L.
Abstract:
Is Part Of:: Annals of oncology. Volume 28(2017)Supplement 5
Journal:: Annals of oncology
Issue:: Volume 28(2017)Supplement 5
Issue Display:: Volume 28, Issue 5 (2017)
Year:: 2017
Volume:: 28
Issue:: 5
Issue Sort Value:: 2017-0028-0005-0000
Page Start:
Page End:
Publication Date:: 2017-09-18
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx380.080 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12574.xml